share_log

《復牌公告》中國中藥(00570.HK)獲國藥集團每股4.6元提私有化

AASTOCKS ·  Feb 22 02:40

中國中藥(00570.HK)公布,國藥集團共裕建議通過計劃安排方式將公司私有化,每股現金價4.6元,較停牌前收報溢價34.11%。涉資約156.5億元。生效後,公司將申請撤銷股份在聯交所的上市地位。

目前,國藥集團持有要約人55.11%股權,要約人及其一致行動人士持有公司股本33.13%。公司股份申請周四(22日)恢復買賣。

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment